Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
---|
05/13/2004 | CA2503786A1 Compounds having both alpha7 nicotinic agonist activity and 5ht, antagonist activity for treatment of cns diseases |
05/12/2004 | EP1418207A1 Mu-oxo bridged heterometal compound and selective production method thereof |
05/12/2004 | EP0799827B1 Acrylamide derivatives and process for producing the same |
05/12/2004 | CN1496262A Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
05/12/2004 | CN1495908A Molecular device and array, rectifier and method, sensor and relative device |
05/11/2004 | US6734313 Reacting ester or carbonate with trialkyl oxonium ion and a non- coordinating anion other than (et3o) (bf4); cyclization, etherification |
05/11/2004 | US6734209 Synthetic salicylihalamides, apicularens and derivatives thereof |
05/06/2004 | WO2004037827A1 Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates |
05/06/2004 | WO2004037823A1 Purine compounds and uses thereof as cannabinoid receptor ligands |
05/06/2004 | WO2004022537A3 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
05/06/2004 | WO2003050082A3 Regioisomerically pure oxochlorins and methods of synthesis |
05/06/2004 | US20040087577 Anti-infective agents |
05/06/2004 | US20040086851 Anticancer agents |
05/06/2004 | EP1415992A1 Diamine derivatives |
05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
04/29/2004 | WO2004034976A2 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer nd anti-infective agents |
04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
04/29/2004 | US20040081959 Using oligonucleotide detectors; hybridization analyzing |
04/29/2004 | CA2501942A1 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
04/28/2004 | EP1413582A1 Dimeric pyrrolobenzodiazepines |
04/28/2004 | EP1412362A1 Chemical compounds |
04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
04/28/2004 | CN1492871A Isoxazoline derivatives as anti-depressants |
04/27/2004 | US6727358 Nonlinear optical or electrical response |
04/27/2004 | US6727356 Fluorescent quenching detection reagents and methods |
04/22/2004 | WO2004033456A2 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors |
04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
04/22/2004 | US20040077663 Thienopyrimidine-based inhibitors of the src family |
04/22/2004 | US20040077652 Treating obsessive compulsive disorder, panic attacks, sexual disorders, eating disorders, obesity, drug abuse and ethanol or cocaine dependence; anxiolytic agents |
04/22/2004 | US20040077622 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
04/22/2004 | US20040077606 Anticancer, antiangiogenic agents; such as imidazo(1,5-a)-pyrazine-1,3-dione derivatives |
04/22/2004 | US20040077605 Cancer, immune disorders; such as 6-hydroxy-4-methyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)-benzonitrile |
04/21/2004 | EP1409491A2 Thienopyrimidine-based inhibitors of the src family |
04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
04/20/2004 | US6723847 3-oxo-n-(5-phenyl-2-pyrimidinyl)spiro(4-azaisobenzofuran-1 (3h),1'-cyclohexane)-4'-carboxamide; neuropeptide y receptor antagonists |
04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
04/15/2004 | WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase |
04/15/2004 | WO2004031173A1 Novel direct black dyes with three heteroaromatic rings |
04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
04/15/2004 | US20040072896 Antiprotozoa agents |
04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
04/15/2004 | US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
04/14/2004 | CN1488633A Large ring lactone antibiotic and preparing method thereof |
04/13/2004 | US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
04/08/2004 | WO2004029056A1 [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE |
04/08/2004 | WO2004029055A1 Fused azole-pyrimidine derivatives |
04/08/2004 | WO2004028476A2 Artemisinin-derived trioxane dimers |
04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
04/08/2004 | WO2004014150A9 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
04/08/2004 | US20040067974 Alzheimer's disease; Down's syndrome; synergistic mixture containing galanthamine |
04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
04/08/2004 | US20040067951 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof |
04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
04/08/2004 | CA2500228A1 [1,2,4]-triazolo[1,5-c]pyrimidine derivative |
04/07/2004 | EP1405852A1 Diamine derivatives |
04/07/2004 | EP1404683A2 Polymerisable charge transport compounds |
04/07/2004 | EP1404675A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
04/07/2004 | EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
04/07/2004 | EP1104424B1 Process for the synthesis of carbapenem intermediates |
04/06/2004 | US6716979 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes |
04/01/2004 | WO2004026882A1 Process for the preparation of cephems |
04/01/2004 | WO2004026871A1 Novel pyrazolopyridine derivatves as pharmaceutical agents |
04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
04/01/2004 | US20040063778 Compounds having improved stability over that of natural benzolactones, and a process for synthesizing them; anticancer activity and inhibit V-ATPase activity |
04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
04/01/2004 | US20040063687 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
04/01/2004 | US20040062952 Novel heterocyclic compounds, materials for light emitting devices and light emitting devices using the same |
03/31/2004 | EP1401839A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta a]naphthalene |
03/31/2004 | EP1401838A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
03/31/2004 | EP1401835A1 Carboline derivatives as pde-5 inhibitors |
03/31/2004 | EP1037865A4 Synthesis of cc-1065/duocarmycin analogs |
03/31/2004 | CN1486322A Novel carbapenem derivatives |
03/31/2004 | CN1486314A Aminotriazolopyridiine derivatives as adenosine receptor ligands |
03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
03/30/2004 | US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders |
03/25/2004 | WO2003080624A3 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
03/25/2004 | WO2003077862A3 Potent, simplified derivatives of immunosuppressive agents |
03/25/2004 | WO2003074523A3 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
03/25/2004 | US20040060077 Using dietary restriction to lower serum insulin levels and function as tool in treatment and prevention of alzheimer's diseases |
03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
03/24/2004 | EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
03/24/2004 | EP1399161A2 Sustained-release analgesic compounds |